OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Gamma Oscillations and Potassium Channel Modulation in Schizophrenia: Targeting GABAergic Dysfunction
Stephen Kaar, Judith Nottage, Ilinca Angelescu, et al.
Clinical EEG and Neuroscience (2023) Vol. 55, Iss. 2, pp. 203-213
Open Access | Times Cited: 12
Stephen Kaar, Judith Nottage, Ilinca Angelescu, et al.
Clinical EEG and Neuroscience (2023) Vol. 55, Iss. 2, pp. 203-213
Open Access | Times Cited: 12
Showing 12 citing articles:
Schizophrenia: from neurochemistry to circuits, symptoms and treatments
Oliver Howes, Bernard R Bukala, Katherine Beck
Nature Reviews Neurology (2023) Vol. 20, Iss. 1, pp. 22-35
Closed Access | Times Cited: 46
Oliver Howes, Bernard R Bukala, Katherine Beck
Nature Reviews Neurology (2023) Vol. 20, Iss. 1, pp. 22-35
Closed Access | Times Cited: 46
New Drug Treatments for Schizophrenia: A Review of Approaches to Target Circuit Dysfunction
Oliver Howes, Eleanor Dawkins, Maria Lobo, et al.
Biological Psychiatry (2024) Vol. 96, Iss. 8, pp. 638-650
Open Access | Times Cited: 14
Oliver Howes, Eleanor Dawkins, Maria Lobo, et al.
Biological Psychiatry (2024) Vol. 96, Iss. 8, pp. 638-650
Open Access | Times Cited: 14
Targeted therapy improves cellular dysfunction, ataxia, and seizure susceptibility in a model of a progressive myoclonus epilepsy
Huijie Feng, Jérôme Clatot, Keisuke Kaneko, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101389-101389
Open Access | Times Cited: 9
Huijie Feng, Jérôme Clatot, Keisuke Kaneko, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101389-101389
Open Access | Times Cited: 9
Potassium channels in behavioral brain disorders. Molecular mechanisms and therapeutic potential: A narrative review
Kazi Asraful Alam, Pernille Svalastoga, Aurora Martı́nez, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 152, pp. 105301-105301
Open Access | Times Cited: 14
Kazi Asraful Alam, Pernille Svalastoga, Aurora Martı́nez, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 152, pp. 105301-105301
Open Access | Times Cited: 14
Case Report: Targeted treatment by fluoxetine/norfluoxetine of a KCNC2 variant causing developmental and epileptic encephalopathy
Ping Li, Alice Butler, Zhou Yu, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Ping Li, Alice Butler, Zhou Yu, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
GABAergic and inflammatory changes in the frontal cortex following neonatal PCP plus isolation rearing, as a dual-hit neurodevelopmental model for schizophrenia
Jennifer Cale, Ethan J. Chauhan, Joshua J. Cleaver, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 9, pp. 6968-6983
Open Access | Times Cited: 2
Jennifer Cale, Ethan J. Chauhan, Joshua J. Cleaver, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 9, pp. 6968-6983
Open Access | Times Cited: 2
Current emerging therapeutic targets and clinical investigational agents for schizophrenia: Challenges and opportunities
Na Ye, Qi Wang, Yue Li, et al.
Medicinal Research Reviews (2024)
Closed Access | Times Cited: 2
Na Ye, Qi Wang, Yue Li, et al.
Medicinal Research Reviews (2024)
Closed Access | Times Cited: 2
SynCAM1 deficiency in the hippocampal parvalbumin interneurons contributes to sevoflurane‐induced cognitive impairment in neonatal rats
Ming‐ming Zhao, Hanwen Gu, Wei‐tong Pan, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 6
Ming‐ming Zhao, Hanwen Gu, Wei‐tong Pan, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 6
Developmental dynamics of the prefrontal cortical SST and PV interneuron networks: Insights from the monkey highlight human-specific features
Nafiseh S Hosseini Fin, Adrian YS Yip, Leon Teo, et al.
(2024)
Open Access | Times Cited: 1
Nafiseh S Hosseini Fin, Adrian YS Yip, Leon Teo, et al.
(2024)
Open Access | Times Cited: 1
Potassium channel modulators and schizophrenia: an overview of investigational drugs
Meghan Musselman, Eric Huynh, Rachana Kelshikar, et al.
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 6, pp. 471-477
Closed Access | Times Cited: 4
Meghan Musselman, Eric Huynh, Rachana Kelshikar, et al.
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 6, pp. 471-477
Closed Access | Times Cited: 4
Transcranial direct-current stimulation of the prefrontal cortex enhances working memory and suppresses pathological gamma power elevation in schizophrenia
Oded Meiron, Asaf Yaniv, Sylvie Rozenberg, et al.
Expert Review of Neurotherapeutics (2023) Vol. 24, Iss. 2, pp. 217-226
Closed Access | Times Cited: 4
Oded Meiron, Asaf Yaniv, Sylvie Rozenberg, et al.
Expert Review of Neurotherapeutics (2023) Vol. 24, Iss. 2, pp. 217-226
Closed Access | Times Cited: 4
Dysfunctional Parvalbumin Neurons in Schizophrenia and the Pathway to the Clinical Application of Kv3 Channel Modulators
Masaya Yanagi, Mamoru Hashimoto
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8696-8696
Open Access
Masaya Yanagi, Mamoru Hashimoto
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8696-8696
Open Access
